Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

2.
3.

Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?

Schütz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M.

Ther Drug Monit. 1996 Jun;18(3):228-33.

PMID:
8738760
4.

[Azathioprine-associated severe myelosuppression: indication of routine determination of thiopurine S-methyltransferase variant?].

Ngo S, Sauvetre G, Vittecoq O, Lévesque H, Marie I.

Rev Med Interne. 2011 Jun;32(6):373-6. doi: 10.1016/j.revmed.2010.09.006. Epub 2010 Oct 20. French.

PMID:
20970225
5.

Is thiopurine methyltransferase genetic polymorphism a major factor for withdrawal of azathioprine in rheumatoid arthritis patients?

Corominas H, Domènech M, Laíz A, Gich I, Geli C, Díaz C, de Cuevillas F, Moreno M, Vázquez G, Baiget M.

Rheumatology (Oxford). 2003 Jan;42(1):40-5.

PMID:
12509611
6.

Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.

Clunie GP, Lennard L.

Rheumatology (Oxford). 2004 Jan;43(1):13-8. Epub 2003 Oct 17. Review.

PMID:
14566029
7.

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine.

Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC, Collie-Duguid ES, Reid DM.

Ann Intern Med. 1998 Nov 1;129(9):716-8.

PMID:
9841604
9.

Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study.

Escousse A, Mousson C, Santona L, Zanetta G, Mounier J, Tanter Y, Duperray F, Rifle G, Chevet D.

Transplant Proc. 1995 Apr;27(2):1739-42. No abstract available.

PMID:
7725481
10.

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.

Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.

Ther Drug Monit. 2005 Aug;27(4):435-41.

PMID:
16044099
11.

Pharmacological monitoring of azathioprine therapy.

Reuther LO, Sonne J, Larsen NE, Larsen B, Christensen S, Rasmussen SN, Tofteng F, Haaber A, Johansen N, Kjeldsen J, Schmiegelow K.

Scand J Gastroenterol. 2003 Sep;38(9):972-7.

PMID:
14531535
12.
13.

Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C.

Lee MN, Woo HI, Lee YM, Kang B, Kim JW, Choe YH, Lee SY.

Yonsei Med J. 2013 Nov;54(6):1545-9. doi: 10.3349/ymj.2013.54.6.1545.

14.

Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.

Dewit O, Moreels T, Baert F, Peeters H, Reenaers C, de Vos M, Van Hootegem P, Muls V, Veereman G, Mana F, Van Outryve M, Holvoet J, Naegels S, Piessevaux H, Horsmans Y, Gala JL; Belgian Inflammatory Bowel Disease Research Group (BIRD).

Clin Biochem. 2011 Sep;44(13):1062-6. doi: 10.1016/j.clinbiochem.2011.06.079. Epub 2011 Jun 24.

PMID:
21723857
15.

Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age.

de Boer NK, van Bodegraven AA, de Graaf P, van der Hulst RW, Zoetekouw L, van Kuilenburg AB.

Ther Drug Monit. 2008 Jun;30(3):390-3. doi: 10.1097/FTD.0b013e31816c20b3.

PMID:
18520612
16.
17.

Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.

Ishioka S, Hiyama K, Sato H, Yamanishi Y, McLeod HL, Kumagai K, Maeda H, Yamakido M.

Intern Med. 1999 Dec;38(12):944-7.

18.

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.

Pharmacogenetics. 2002 Aug;12(6):429-36.

PMID:
12172211
19.
20.

Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.

Stolk JN, Boerbooms AM, de Abreu RA, de Koning DG, van Beusekom HJ, Muller WH, van de Putte LB.

Arthritis Rheum. 1998 Oct;41(10):1858-66.

PMID:
9778228

Supplemental Content

Support Center